Works matching AU Augustin, M.

Results: 377
    1

    Elucidating steroid alkaloid biosynthesis in Veratrum californicum: production of verazine in Sf9 cells.

    Published in:
    Plant Journal, 2015, v. 82, n. 6, p. 991, doi. 10.1111/tpj.12871
    By:
    • Augustin, Megan M.;
    • Ruzicka, Dan R.;
    • Shukla, Ashutosh K.;
    • Augustin, Jörg M.;
    • Starks, Courtney M.;
    • O'Neil‐Johnson, Mark;
    • McKain, Michael R.;
    • Evans, Bradley S.;
    • Barrett, Matt D.;
    • Smithson, Ann;
    • Wong, Gane Ka‐Shu;
    • Deyholos, Michael K.;
    • Edger, Patrick P.;
    • Pires, J. Chris;
    • Leebens‐Mack, James H.;
    • Mann, David A.;
    • Kutchan, Toni M.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angioedema.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 11, p. 2056, doi. 10.1111/jdv.20157
    By:
    • Chernyshov, P. V.;
    • Finlay, A. Y.;
    • Tomas‐Aragones, L.;
    • Zuberbier, T.;
    • Kocatürk, E.;
    • Manolache, L.;
    • Pustisek, N.;
    • Svensson, A.;
    • Marron, S. E.;
    • Sampogna, F.;
    • Bewley, A.;
    • Salavastru, C.;
    • Koumaki, D.;
    • Augustin, M.;
    • Linder, D.;
    • Abeni, D.;
    • Salek, S. S.;
    • Szepietowski, J.;
    • Jemec, G. B.
    Publication type:
    Article
    20

    Chronic nodular prurigo: Association between comorbidities, itch and quality of life.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 11, p. e984, doi. 10.1111/jdv.20038
    By:
    • Pereira, M. P.;
    • Gutsche, A.;
    • Weisshaar, E.;
    • Halvorsen, J. A.;
    • Wallengren, J.;
    • Legat, F. J.;
    • Garcovich, S.;
    • Savk, E.;
    • Reich, A.;
    • Bozek, A.;
    • Lvov, A.;
    • Bobko, S.;
    • Metz, M.;
    • Streit, M.;
    • Misery, L.;
    • Brenaut, E.;
    • Serra‐Baldrich, E.;
    • Goncalo, M.;
    • Szepietowski, J. C.;
    • Augustin, M.
    Publication type:
    Article
    21
    22
    23

    Quality of life measurement in teledermatology. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Teledermatology.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 2, p. 254, doi. 10.1111/jdv.19570
    By:
    • Chernyshov, P. V.;
    • Finlay, A. Y.;
    • Tomas‐Aragones, L.;
    • Tognetti, L.;
    • Moscarella, E.;
    • Pasquali, P.;
    • Manolache, L.;
    • Pustisek, N.;
    • Svensson, A.;
    • Marron, S. E.;
    • Bewley, A.;
    • Salavastru, C.;
    • Suru, A.;
    • Koumaki, D.;
    • Linder, D.;
    • Abeni, D.;
    • Augustin, M.;
    • Blome, C.;
    • Salek, S. S.;
    • Evers, A. W. M.
    Publication type:
    Article
    24
    25
    26
    27
    28

    Quality of life measurement in rosacea. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 5, p. 954, doi. 10.1111/jdv.18918
    By:
    • Chernyshov, P. V.;
    • Finlay, A. Y.;
    • Tomas‐Aragones, L.;
    • Steinhoff, M.;
    • Manolache, L.;
    • Pustisek, N.;
    • Dessinioti, C.;
    • Svensson, A.;
    • Marron, S. E.;
    • Bewley, A.;
    • Salavastru, C.;
    • Dréno, B.;
    • Suru, A.;
    • Koumaki, D.;
    • Linder, D.;
    • Evers, A. W. M.;
    • Abeni, D.;
    • Augustin, M.;
    • Salek, S. S.;
    • Nassif, A.
    Publication type:
    Article
    29
    30
    31
    32

    Secukinumab demonstrated sustained retention, effectiveness and safety in a real‐world setting in patients with moderate‐to‐severe plaque psoriasis: long‐term results from an interim analysis of the SERENA study.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 10, p. 1796, doi. 10.1111/jdv.18329
    By:
    • Augustin, M.;
    • Sator, P.G.;
    • von Kiedrowski, R.;
    • Conrad, C.;
    • Rigopoulos, D.;
    • Romanelli, M.;
    • Ghislain, P.‐D.;
    • Torres, T.;
    • Ioannides, D.;
    • Aassi, M.;
    • Schulz, B.;
    • Jagiello, P.
    Publication type:
    Article
    33
    34
    35
    36

    Atopic dermatitis and depressive symptoms. Results of the German national AD Registry TREATgermany.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 4, p. e279, doi. 10.1111/jdv.17812
    By:
    • Helmert, C.;
    • Haufe, E.;
    • Heinrich, L.;
    • Siegels, D.;
    • Abraham, S.;
    • Heratizadeh, A.;
    • Harder, I.;
    • Kleinheinz, A.;
    • Wollenberg, A.;
    • Wiemers, F.;
    • Weisshaar, E.;
    • Augustin, M.;
    • von Kiedrowski, R.;
    • Zink, A.;
    • Pawlak, M.;
    • Schäkel, K.;
    • Wildberger, J.;
    • Weidinger, S.;
    • Werfel, T.;
    • Schmitt, J.
    Publication type:
    Article
    37
    38
    39

    Atopic dermatitis: disease characteristics and comorbidities in smoking and non‐smoking patients from the TREATgermany registry.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 3, p. 413, doi. 10.1111/jdv.17789
    By:
    • Pilz, A.C.;
    • Schielein, M.C.;
    • Schuster, B.;
    • Heinrich, L.;
    • Haufe, E.;
    • Abraham, S.;
    • Heratizadeh, A.;
    • Harder, I.;
    • Kleinheinz, A.;
    • Wollenberg, A.;
    • Wiemers, F.;
    • Weisshaar, E.;
    • Augustin, M.;
    • von Kiedrowski, R.;
    • Pawlak, M.;
    • Schäkel, K.;
    • Wildberger, J.;
    • Hilgers, M.;
    • Werfel, T.;
    • Weidinger, S.
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Quality of life measurement in alopecia areata. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 8, p. 1614, doi. 10.1111/jdv.17370
    By:
    • Chernyshov, P.V.;
    • Tomas‐Aragones, L.;
    • Finlay, A.Y.;
    • Manolache, L.;
    • Marron, S.E.;
    • Sampogna, F.;
    • Spillekom‐van Koulil, S.;
    • Pustisek, N.;
    • Suru, A.;
    • Evers, A.W.M.;
    • Salavastru, C.;
    • Svensson, A.;
    • Abeni, D.;
    • Blome, C.;
    • Poot, F.;
    • Jemec, G.B.E.;
    • Linder, D.;
    • Augustin, M.;
    • Bewley, A.;
    • Salek, S.S.
    Publication type:
    Article
    49

    Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatitis from the BREEZE‐AD7 Phase 3 randomized trial.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 7, p. 1543, doi. 10.1111/jdv.17278
    By:
    • Wollenberg, A.;
    • Nakahara, T.;
    • Maari, C.;
    • Peris, K.;
    • Lio, P.;
    • Augustin, M.;
    • Silverberg, J.I.;
    • Rueda, M.J.;
    • DeLozier, A.M.;
    • Pierce, E.;
    • Yang, F.E.;
    • Sun, L.;
    • Ball, S.;
    • Tauber, M.;
    • Paul, C.
    Publication type:
    Article
    50